Kristensen G - Search Results

1

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.

Rustin GJ, van der Burg ME, Griffin CL, Guthrie D, Lamont A, Jayson GC, Kristensen G, Mediola C, Coens C, Qian W, Parmar MK, Swart AM; MRC OV05; EORTC 55955 investigators. Rustin GJ, et al. Among authors: kristensen g. Lancet. 2010 Oct 2;376(9747):1155-63. doi: 10.1016/S0140-6736(10)61268-8. Lancet. 2010. PMID: 20888993 Free article. Clinical Trial.

2

Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis.

Makar AP, Kristensen GB, Kaern J, Børmer OP, Abeler VM, Tropé CG. Makar AP, et al. Among authors: kristensen gb. Obstet Gynecol. 1992 Jun;79(6):1002-10. Obstet Gynecol. 1992. PMID: 1579296

3

A randomised study of cisplatin versus thiotepa as induction chemotherapy in advanced ovarian carcinoma.

Dørum A, Kristensen GB, Tropé C. Dørum A, et al. Among authors: kristensen gb. Eur J Cancer. 1994;30A(10):1470-4. doi: 10.1016/0959-8049(94)00240-6. Eur J Cancer. 1994. PMID: 7833104 Clinical Trial.

4

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer.

Makar AP, Baekelandt M, Tropé CG, Kristensen GB. Makar AP, et al. Among authors: kristensen gb. Gynecol Oncol. 1995 Feb;56(2):175-80. doi: 10.1006/gyno.1995.1027. Gynecol Oncol. 1995. PMID: 7896181

5

Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.

Kaern J, Tropé CG, Kristensen GB, Tveit KM, Pettersen EO. Kaern J, et al. Among authors: kristensen gb. Am J Obstet Gynecol. 1994 Feb;170(2):479-87. doi: 10.1016/s0002-9378(94)70215-2. Am J Obstet Gynecol. 1994. PMID: 8116701

6

Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.

Kaern J, Tropé CG, Kristensen GB, Pettersen EO. Kaern J, et al. Among authors: kristensen gb. Cancer. 1994 Apr 1;73(7):1870-7. doi: 10.1002/1097-0142(19940401)73:7<1870::aid-cncr2820730716>3.0.co;2-3. Cancer. 1994. PMID: 8137213

7

A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinoma.

Kristensen GB, Baekelandt M, Vergote IB, Tropé C. Kristensen GB, et al. Eur J Cancer. 1995 Oct;31A(11):1778-80. doi: 10.1016/0959-8049(95)00274-m. Eur J Cancer. 1995. PMID: 8541099 Clinical Trial.

8

Cisplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-up.

Kaern J, Tropé C, Sundfoer K, Kristensen GB. Kaern J, et al. Among authors: kristensen gb. Gynecol Oncol. 1996 Mar;60(3):387-92. doi: 10.1006/gyno.1996.0059. Gynecol Oncol. 1996. PMID: 8774643 Clinical Trial.

9

Early detection of familial ovarian cancer.

Dørum A, Kristensen GB, Abeler VM, Tropé CG, Møller P. Dørum A, et al. Among authors: kristensen gb. Eur J Cancer. 1996 Sep;32A(10):1645-51. doi: 10.1016/0959-8049(96)00137-2. Eur J Cancer. 1996. PMID: 8983269 Clinical Trial.

10

Epithelial ovarian carcinoma.

Kristensen GB, Tropé C. Kristensen GB, et al. Lancet. 1997 Jan 11;349(9045):113-7. doi: 10.1016/S0140-6736(96)06071-0. Lancet. 1997. PMID: 8996432 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

364 results

Search Page